Targeting cancer cell dormancy
A Recasens, L Munoz - Trends in pharmacological sciences, 2019 - cell.com
Cancer cell dormancy is a process whereby cells enter reversible cell cycle arrest, termed
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
[引用][C] Targeting Cancer Cell Dormancy
A Recasens, L Munoz - Trends in Pharmacological Sciences, 2019 - cir.nii.ac.jp
Targeting Cancer Cell Dormancy
A Recasens, L Munoz - Trends in pharmacological …, 2019 - pubmed.ncbi.nlm.nih.gov
Cancer cell dormancy is a process whereby cells enter reversible cell cycle arrest, termed
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
Targeting Cancer Cell Dormancy
A Recasens, L Munoz - Trends in Pharmacological Sciences, 2019 - Elsevier
HighlightsDormancy is essential for cancer cells to acquire additional mutations, to survive
in a new environment and initiate metastasis, to become resistant to cancer therapy, and to …
in a new environment and initiate metastasis, to become resistant to cancer therapy, and to …
Targeting Cancer Cell Dormancy.
A Recasens, L Munoz - Trends in Pharmacological Sciences, 2019 - europepmc.org
Cancer cell dormancy is a process whereby cells enter reversible cell cycle arrest, termed
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
Targeting Cancer Cell Dormancy
A Recasens, L Munoz - Trends in Pharmacological Sciences, 2019 - cell.com
Cancer cell dormancy is a process whereby cells enter reversible cell cycle arrest, termed
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …
quiescence. Quiescence is essential for cancer cells to acquire additional mutations, to …